Description
Understanding the GE 4DE7C Endovaginal Ultrasound Probe
Condition:Used : An item that has been used previously. The item may have some signs of cosmetic wear, but is fully operational and functions as intended. This item may be a floor model or store return that has been used. See the sellerâs listing for full details and description of any imperfections. See all condition definitions- opens in a new window or tab
Seller Notes:âFully functional. Tested using a GE Logiq 9 with a breast phantom. Shows signs of use. Includes everything shown.â
Brand: GE Healtcare
Country/Region of Manufacture: United States
MPN: Does Not Apply
Model: 4DE7C Endovaginal Ultrasound Transducer Probe 3D/4
UPC: Does not apply
Advanced Imaging Technology
The GE 4DE7C ultrasound probe uses cutting-edge technology to deliver high-resolution 3D and 4D imaging. This capability enhances the visualization of internal structures. A clearer image can aid in diagnoses and understanding of various conditions. Additionally, the probe's design ensures patient comfort during procedures. So, because of this advanced imaging technology, healthcare providers can obtain more accurate results efficiently.
Enhanced Patient Experience
One feature of the GE ultrasound probe is its ergonomic design. This design reduces discomfort during examinations, making the experience more pleasant for patients. Moreover, the probe is lightweight, allowing easy maneuverability for healthcare professionals. This is essential for lengthy procedures where precision is critical. Therefore, patients can feel at ease, contributing to better overall results.
Applications in Medical Practice
The applications of the GE 4DE7C probe are diverse, ranging from gynecological assessments to developmental evaluations in obstetrics. Healthcare providers rely on the clarity and detail of 3D and 4D imaging for better decision-making. With accurate imaging, treatment plans can be tailored more effectively. Consequently, clinicians can provide a higher standard of care, which benefits patient outcomes significantly.














